Mutual Amplification of GLI2 /Hedgehog and Transcription Factor JUN / AP ‐1 Signaling in Fibroblasts in Systemic Sclerosis: Potential Implications for Combined Therapies
Arthritis & Rheumatology · 2025
DOI: 10.1002/art.42979 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2025. Verfasst von Christina Bergmann und 20 weiteren Autor:innen. Beteiligte Einrichtung: Deutsches Zentrum für Immuntherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany. Hauptthemen laut MEDLINE: Fibroblasts, Zinc Finger Protein Gli2, Scleroderma, Systemic, Hedgehog Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Else-Kröner-Fresenius-Stiftung, Wilhelm-Sander-Stiftung, Interdisziplinäres Zentrum für Klinische Forschung, Erlangen.
Abstract (Originalsprache)
Objective
Deregulation of the cJUN/AP‐1 and hedgehog/GLI2 signaling pathways has been implicated in fibroblast activation in systemic sclerosis (SSc). However, the consequences of their concomitant up‐regulation are unknown. Here, we tested the hypothesis that mutual amplification of both pathways might drive persistent fibroblast activation.
Methods
Cultured fibroblasts and skin sections of patients with diffuse SSc and healthy volunteers were analyzed. cJUN/AP‐1 signaling and hedgehog/GLI2 signaling were inhibited using knockdown and pharmacologic approaches. Hedgehog signaling was activated in mice by fibroblast‐specific overexpression of constitutively active Smoothened. Results cJUN and GLI2 are concomitantly up‐regulated and colocalize in fibroblasts of patients with SSc compared to healthy controls. Activation of hedgehog/GLI2 signaling induces the expression of cJUN in vitro and in vivo, whereas inactivation of GLI2 inhibits cJUN expression. Likewise, inactivation of cJUN impairs the expression of GLI2. This mutual regulation occurs at the level of transcription with binding of cJUN and GLI2 to specific binding motifs. Interference with this mutual amplification of cJUN signaling and GLI2 signaling inhibits fibroblast activation and collagen release: Inhibition of cJUN/AP‐1 signaling ameliorates hedgehog‐induced fibroblast activation and skin fibrosis in Smo ACT mice with a reduction of skin thickness of 103% ( P = 0.0043) in the treatment group compared to the fibrotic control group. Moreover, combined pharmacologic inhibition of cJUN/AP‐1 and hedgehog/GLI2 exerts additive antifibrotic effects in a model of TGFβ‐driven experimental fibrosis (TBR ACT mice).
Conclusion
The transcription factors cJUN and GLI2 reinforce each other's activity to promote fibroblast activation in SSc. Interruption of this crosstalk by combined inhibition of both pathways exerts additive antifibrotic effects at well‐tolerated doses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Deutsches Zentrum für Immuntherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.
- Hiller Research Center, University Hospital Düsseldorf and Heinrich Heine University, Düsseldorf, Germany.
- Institute of Human Genetics, Friedrich Alexander Universität Erlangen-Nürnberg, and Uniklinikum Erlangen, Erlangen, Germany.
- Xiangya Hospital, Central South University, Changsha, China.
- Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
- Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, and Fraunhofer Institute for Toxicology and Experimental Medicine and Fraunhofer Cluster of Excellence Immune-Mediated Diseases, Hannover, Germany.
ORCID-Profile: Christina Bergmann, Honglin Zhu, Alexandru-Emil Matei, Andrea-Hermina Györfi, Georg Schett, Jörg H W Distler
Förderung
- Else-Kröner-Fresenius-Stiftung
- Wilhelm-Sander-Stiftung
- Interdisziplinäres Zentrum für Klinische Forschung, Erlangen
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Fraunhofer Cluster of Excellence Immune-Mediated Diseases
- Clinician Scientist Program
Zitieren
APA
Bergmann, C., Chenguiti Fakhouri, S., Trinh-Minh, T., Filla, T., Rius Rigau, A., Ekici, A. B., Merlevede, B., Hallenberger, L., Zhu, H., Dees, C., Matei, A. E., Auth, J., Györfi, A. H., Zhou, X., Rauber, S., Bozec, A., Dickel, N., Liang, C., Kunz, M., …, & Distler, J. H. W. (2025). Mutual Amplification of GLI2 /Hedgehog and Transcription Factor JUN / AP ‐1 Signaling in Fibroblasts in Systemic Sclerosis: Potential Implications for Combined Therapies. Arthritis & Rheumatology. https://doi.org/10.1002/art.42979
Vancouver
Bergmann C, Chenguiti Fakhouri S, Trinh-Minh T, Filla T, Rius Rigau A, Ekici AB, et al. Mutual Amplification of GLI2 /Hedgehog and Transcription Factor JUN / AP ‐1 Signaling in Fibroblasts in Systemic Sclerosis: Potential Implications for Combined Therapies. Arthritis & Rheumatology. 2025. doi:10.1002/art.42979
BibTeX
@article{Bergmann2025,
author = {Bergmann, Christina and Chenguiti Fakhouri, Sara and Trinh-Minh, Thuong and Filla, Tim and Rius Rigau, Aleix and Ekici, Arif B and Merlevede, Benita and Hallenberger, Ludwig and Zhu, Honglin and Dees, Clara and Matei, Alexandru-Emil and Auth, Janina and Györfi, Andrea-Hermina and Zhou, Xiang and Rauber, Simon and Bozec, Aline and Dickel, Nicholas and Liang, Chunguang and Kunz, Meik and Schett, Georg and Distler, Jörg H W},
title = {Mutual Amplification of GLI2 /Hedgehog and Transcription Factor JUN / AP ‐1 Signaling in Fibroblasts in Systemic Sclerosis: Potential Implications for Combined Therapies},
journal = {Arthritis & Rheumatology},
year = {2025},
doi = {10.1002/art.42979}
}
EUVIMED